Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network
- 12 December 2006
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 119 (1) , 3-11
- https://doi.org/10.1016/j.jaci.2006.10.015
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Characterization of within-subject responses to fluticasone and montelukast in childhood asthmaJournal of Allergy and Clinical Immunology, 2005
- Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialPublished by Elsevier ,2004
- Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapiesJournal of Allergy and Clinical Immunology, 2004
- Effect of long‐acting β2 agonists on exacerbation rates of asthma in childrenPediatric Pulmonology, 2003
- Asthma exacerbations during long term beta agonist use: influence of beta 2 adrenoceptor polymorphismThorax, 2000
- Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild AsthmaNew England Journal of Medicine, 1996
- Perspectives in β2-agonist therapy: Vox clamantis in deserto vel lux in tenebris?*Journal of Allergy and Clinical Immunology, 1995
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trialJournal of Allergy and Clinical Immunology, 1992
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992